On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...